Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mia Levite

Showing results (11-20 of 37) with videos related to

Pageof 4
Sort By:
Expert Review of Neurotherapeutics|October 9, 2009
Immunotherapy for epilepsyMia Levite, Ian K Hart
Journal of Neural Transmission (Vienna, Austria : 1996)|August 2, 2014
Glutamate and Vivian Teichberg: a story about science, medicine, memory and loveMia Levite Teichberg, Peter Riederer
Journal of Neural Transmission (Vienna, Austria : 1996)|March 12, 2017
Dopamine, T cells and multiple sclerosis (MS)Mia Levite, Franca Marino, Marco Cosentino
Journal of Neuroimmunology|September 10, 2005
Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or bothMichal J Besser, Yonatan Ganor, Mia Levite
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavageYonatan Ganor, Vivian I Teichberg, Mia Levite
Autoimmunity|July 26, 2005
Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokinesYonatan Ganor, Michael Freilinger, Olivier Dulac, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Empowering exhausted T cells of Glioblastoma patients by Neurotransmitters and Neuropeptides: decreasing immune checkpoint inhibitors, and increasing CD3zeta, proliferation and Glioblastoma arrestMia Levite, Nili Ilouz, Eithan Galun, et al.
Neuropeptides|July 22, 2021
Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cellsMia Levite, Rifaat Safadi, Yael Milgrom, et al.
Neurochemical Research|September 13, 2006
Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channelsKatayun Cohen-Kashi Malina, Yonatan Ganor, Mia Levite, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migrationYonatan Ganor, Michal Besser, Naomie Ben-Zakay, et al.
Pageof 4

Showing results (11-20 of 37) with videos related to

Sort By:
Pageof 4
Expert Review of Neurotherapeutics|October 9, 2009
Immunotherapy for epilepsyMia Levite, Ian K Hart
Journal of Neural Transmission (Vienna, Austria : 1996)|August 2, 2014
Glutamate and Vivian Teichberg: a story about science, medicine, memory and loveMia Levite Teichberg, Peter Riederer
Journal of Neural Transmission (Vienna, Austria : 1996)|March 12, 2017
Dopamine, T cells and multiple sclerosis (MS)Mia Levite, Franca Marino, Marco Cosentino
Journal of Neuroimmunology|September 10, 2005
Dopamine by itself activates either D2, D3 or D1/D5 dopaminergic receptors in normal human T-cells and triggers the selective secretion of either IL-10, TNFalpha or bothMichal J Besser, Yonatan Ganor, Mia Levite
Journal of Immunology (Baltimore, Md. : 1950)|January 5, 2007
TCR activation eliminates glutamate receptor GluR3 from the cell surface of normal human T cells, via an autocrine/paracrine granzyme B-mediated proteolytic cleavageYonatan Ganor, Vivian I Teichberg, Mia Levite
Autoimmunity|July 26, 2005
Monozygotic twins discordant for epilepsy differ in the levels of potentially pathogenic autoantibodies and cytokinesYonatan Ganor, Michael Freilinger, Olivier Dulac, et al.
Cancer Immunology, Immunotherapy : CII|January 27, 2026
Empowering exhausted T cells of Glioblastoma patients by Neurotransmitters and Neuropeptides: decreasing immune checkpoint inhibitors, and increasing CD3zeta, proliferation and Glioblastoma arrestMia Levite, Nili Ilouz, Eithan Galun, et al.
Neuropeptides|July 22, 2021
Neurotransmitters and Neuropeptides decrease PD-1 in T cells of healthy subjects and patients with hepatocellular carcinoma (HCC), and increase their proliferation and eradication of HCC cellsMia Levite, Rifaat Safadi, Yael Milgrom, et al.
Neurochemical Research|September 13, 2006
Autoantibodies against an extracellular peptide of the GluR3 subtype of AMPA receptors activate both homomeric and heteromeric AMPA receptor channelsKatayun Cohen-Kashi Malina, Yonatan Ganor, Mia Levite, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 12, 2003
Human T cells express a functional ionotropic glutamate receptor GluR3, and glutamate by itself triggers integrin-mediated adhesion to laminin and fibronectin and chemotactic migrationYonatan Ganor, Michal Besser, Naomie Ben-Zakay, et al.
Pageof 4